Please note:

Some industry partners have sponsored this meeting via the provision of promotional exhibition stands and/or promotional symposia. They have had no influence on the rest of the meeting’s agenda or speakers.

GSK are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

NP-GB-AAP-COCO-250001 | December 2025

As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Seqirus offers a differentiated portfolio of influenza vaccines worldwide.

GBR-NOPR-26-0020 | July 2026I

Pfizer Vaccines: Helping Protect Life’s Journey

Our history in vaccines stretches as far back as 1882. Today, our organisation is comprised of passionate, world-class employees who work every day to translate cutting-edge science into vaccines. We have a portfolio that covers life threatening illnesses that can be caused by respiratory syncytial virus (RSV), pneumococcal, meningococcal and COVID-19 infections. Also available are our travel vaccines which includes tick-borne encephalitis.

If you have an enquiry about our vaccines and would like to contact the Pfizer UK team, email us directly: customer.services@pfizer.com 

PP-UNP-GBR-13926 January 2026

View the exhibitors 

Aqua Healthcare is a leading provider in Primary Care recruitment. We supply various clinical and non-clinical staff, both salaried and locum to various settings across the United Kingdom. Our specialist consultants provide a bespoke service to both our candidates and clients to insure the best possible care for patients.

Bavarian Nordic UK is the recently launched British affiliate of Bavarian Nordic A/S, a global vaccine manufacturer with headquarters in Denmark. We are a leading global provider of travel vaccines with over 30 years of vaccine excellence, employing more than 1,600 people specialised in research and development, manufacturing and commercialisation of vaccines.

Valneva is a specialty vaccine company focused on the development, manufacturing and commercialisation of prophylactic vaccines for infectious diseases with significant unmet medical need. Our vision is to contribute to a world in which no one dies or suffers from a vaccine-preventable disease.